Singapore markets closed

Altimmune Inc (3G0.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
5.78+0.35 (+6.42%)
At close: 09:53PM CEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
410
426
-68
4,410
8,185
Operating expenses
Research development
70,037
65,799
70,538
74,541
49,774
Selling general and administrative
18,918
18,137
17,134
15,413
13,209
Total operating expenses
88,955
83,936
87,672
89,954
62,984
Operating income or loss
-88,545
-83,510
-87,740
-85,544
-54,799
Interest expense
34
35
8
5
9.421
Total other income/expenses net
-12,284
-12,253
-32
-11,744
24.147
Income before tax
-92,767
-88,447
-84,910
-97,090
-54,462
Income tax expense
-
0
-197
0
-5,417
Income from continuing operations
-92,767
-88,447
-84,713
-97,090
-49,044
Net income
-92,767
-88,447
-84,713
-97,090
-49,044
Net income available to common shareholders
-92,767
-88,447
-84,713
-97,090
-49,044
Basic EPS
-1.54
-1.66
-1.81
-2.35
-1.91
Diluted EPS
-1.54
-1.66
-1.81
-2.35
-1.91
Basic average shares
51,137
53,247
46,926
41,283
25,637
Diluted average shares
51,137
53,247
46,926
41,283
25,637